Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography
- PMID: 16102110
- PMCID: PMC1410193
- DOI: 10.1111/j.1538-7836.2005.01513.x
Evaluation of the profile of thrombin generation during the process of whole blood clotting as assessed by thrombelastography
Abstract
The objective of this study was to evaluate the possibility of linking the tracing of whole blood clotting in a thrombelastograph (TEG) hemostasis system with the generation of thrombin assessed by thrombin/antithrombin complex (TAT). Citrated whole blood containing corn trypsin inhibitor from volunteers was clotted in the presence of CaCl2 and tissue factor. Clotting was monitored with the eight channels of a TEG system. At different time points, the whole blood TEG reaction cups were kept in a cold quenching solution, centrifuged, and the supernatants were kept at -80 degrees C until assayed for TAT by ELISA. The total thrombus generation (TTG) was calculated from the first derivative of the TEG waveform and was compared with thrombin generation measured by TAT. The two vector values--the TAT thrombin generation data and the corresponding TEG TTG--were analyzed using Pearson correlation coefficients (r) and linear, non-linear and natural log (ln) transformation of TAT values for least-squares goodness-of-fit curves. The best least-squares fit is an exponential curve. Linearizing using the ln of the TAT thrombin generation variable produces the same r (0.94) as of the exponential curve. The prediction equation is y = 8.0465 + 0.0005x (P < or = 0.0001), where y is the TAT thrombin generation variable in the ln transformation and x is the TEG TTG variable. The high magnitude of r and the high significance of the prediction equation demonstrate the high efficacy of the prediction of TAT thrombin generation by the use of TEG TTG.
Figures








Similar articles
-
Investigation of the thrombin-generating capacity, evaluated by thrombogram, and clot formation evaluated by thrombelastography of platelets stored in the blood bank for up to 7 days.Vox Sang. 2008 Feb;94(2):113-8. doi: 10.1111/j.1423-0410.2007.01011.x. Epub 2007 Dec 7. Vox Sang. 2008. PMID: 18067490
-
Citrate storage affects Thrombelastograph analysis.Anesthesiology. 2000 May;92(5):1242-9. doi: 10.1097/00000542-200005000-00011. Anesthesiology. 2000. PMID: 10781268 Clinical Trial.
-
Comparison of thrombin-antithrombin complex (TAT) levels and fibrinopeptide A following thrombin incubation of human plasma using hirudin as an inhibitor of TAT formation.Thromb Res. 1991 Feb 1;61(3):253-9. doi: 10.1016/0049-3848(91)90101-2. Thromb Res. 1991. PMID: 2028444
-
Thrombin generation assay and other universal tests for monitoring haemophilia therapy.Haemophilia. 2004 Sep;10 Suppl 2:17-21. doi: 10.1111/j.1365-2516.2004.00936.x. Haemophilia. 2004. PMID: 15385042 Review.
-
[Thrombin, antithrombin, thrombin-antithrombin complex (TAT)].Nihon Rinsho. 2004 Dec;62 Suppl 12:626-8. Nihon Rinsho. 2004. PMID: 15658407 Review. Japanese. No abstract available.
Cited by
-
Targeting thrombogenicity and inflammation in chronic HIV infection.Sci Adv. 2019 Jun 12;5(6):eaav5463. doi: 10.1126/sciadv.aav5463. eCollection 2019 Jun. Sci Adv. 2019. PMID: 31206016 Free PMC article. Clinical Trial.
-
Heparin-like effect contributes to the coagulopathy in patients with acute liver failure undergoing liver transplantation.Liver Int. 2009 May;29(5):754-9. doi: 10.1111/j.1478-3231.2009.01977.x. Epub 2009 Feb 9. Liver Int. 2009. PMID: 19220741 Free PMC article.
-
Optical sensing of anticoagulation status: Towards point-of-care coagulation testing.PLoS One. 2017 Aug 3;12(8):e0182491. doi: 10.1371/journal.pone.0182491. eCollection 2017. PLoS One. 2017. PMID: 28771571 Free PMC article.
-
Comparison of whole blood versus red blood cells and plasma to correct trauma-induced coagulopathy ex vivo.Transfusion. 2025 Mar;65(3):624-636. doi: 10.1111/trf.18143. Epub 2025 Feb 5. Transfusion. 2025. PMID: 39908221 Free PMC article.
-
Exogenous human α-Synuclein acts in vitro as a mild platelet antiaggregant inhibiting α-thrombin-induced platelet activation.Sci Rep. 2022 Jun 14;12(1):9880. doi: 10.1038/s41598-022-12886-y. Sci Rep. 2022. PMID: 35701444 Free PMC article.
References
-
- Lee RI, White PD. A clinical study of the coagulation time of blood. Am J Med Sci. 1913;145:495–503.
-
- Proctor RR, Rapaport SI. The partial thromboplastin time with kaolin. Am J Clin Pathol. 1961;36:212–2190. - PubMed
-
- Yamada K, Meguro T. A new APTT assay employing a chromogenic substrate and a centrifugal autoanalyser. Thromb Res. 1979;15:351–358. - PubMed
-
- Hemker HC, Beguin S. Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thromb Haemost. 1995;74:134–138. - PubMed
-
- Rand MD, Lock JB, ven’t Veer C, Gaffney DP, Mann KG. Blood clotting in minimally altered whole blood. Blood. 1996;88:3432–3445. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources